Analyst Reco. Confluent, Inc.

Equities

CFLT

US20717M1036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
31.54 ^USD	-1.50%		+2.84%	+34.79%

May. 17	Confluent Insider Sold Shares Worth $7,372,575, According to a Recent SEC Filing	MT
May. 17	Oppenheimer Initiates Coverage on Confluent With Outperform Rating, $37 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Confluent Insider Sold Shares Worth $7,372,575, According to a Recent SEC Filing	May. 17	MT
Oppenheimer Initiates Coverage on Confluent With Outperform Rating, $37 Price Target	May. 17	MT
Confluent Insider Sold Shares Worth $1,975,599, According to a Recent SEC Filing	May. 13	MT
Confluent Insider Sold Shares Worth $2,231,961, According to a Recent SEC Filing	May. 13	MT
Goldman Sachs Raises Price Target on Confluent to $30 From $27, Maintains Neutral Rating	May. 09	MT
Wells Fargo Raises Price Target on Confluent to $38 From $36, Maintains Overweight Rating	May. 08	MT
Truist Adjusts Price Target on Confluent to $36 From $33, Maintains Buy Rating	May. 08	MT
Canaccord Genuity Upgrades Confluent to Buy From Hold With $35 Price Target	May. 08	MT
UBS Adjusts Price Target on Confluent to $30 From $28, Maintains Neutral Rating	May. 03	MT
Mizuho Securities Cuts Price Target on Confluent to $36 From $38, Maintains Buy Rating	Apr. 15	MT
Confluent Insider Sold Shares Worth $252,283, According to a Recent SEC Filing	Mar. 22	MT
Needham Raises Price Target on Confluent to $38 From $35, Maintains Buy Rating	Mar. 22	MT
Stifel Starts Confluent With Buy Rating, $40 Price Target	Feb. 21	MT
RBC Lifts PT on Confluent to $37 From $35, Notes Increased Confidence in 2024 Outlook, Multi-Year Opportunity; Outperform Kept	Feb. 14	MT
UBS Adjusts Confluent Price Target to $28 From $26, Maintains Neutral Rating	Feb. 08	MT
Canaccord Genuity Adjusts Price Target on Confluent to $28 From $26, Maintains Hold Rating	Feb. 08	MT
Capital One Adjusts Price Target on Confluent to $38 From $27, Maintains Overweight Rating	Feb. 08	MT
Piper Sandler Adjusts Price Target on Confluent to $37 From $30, Maintains Overweight Rating	Feb. 08	MT
Barclays Adjusts Price Target on Confluent to $33 From $26, Maintains Overweight Rating	Feb. 08	MT
JMP Securities Adjusts Price Target on Confluent to $38 From $25, Maintains Market Outperform Rating	Feb. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Confluent, Inc.

Equities

CFLT

US20717M1036

Analyst Reco.

Filters